Literature DB >> 17426903

Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts.

Paolo Miccoli1, Michele N Minuto, Clara Ugolini, Erica Panicucci, Piero Berti, Marco Massi, Fulvio Basolo.   

Abstract

INTRODUCTION: Total thyroidectomy (TT) remains the treatment of choice for differentiated thyroid carcinomas (DTCs), but a limited approach can be proposed when tumors are at an early stage and limited to a single lobe. The aim of this study was to analyze the pathologic and clinical aspects of a retrospective series of DTCs in an attempt to determine whether these features might prove useful for limiting the surgical strategy in selected cases.
METHODS: From 2000 to 2005, a total of 2798 patients (637 males, 2161 females; mean age 44.6 years) underwent TT for papillary thyroid carcinoma in our department. The histologic features considered were size, histologic subtype and capsule of the tumor, its multifocality/bilaterality, infiltration of the thyroid capsule, and the presence of nodal metastases.
RESULTS: Statistical analysis revealed that among tumors < or = 1 cm the presence of the tumor capsule, infiltration of the thyroid capsule, bilaterality, and the presence of node metastases were all significantly lower when the tumor size was < or = 0.5 cm (p < 0.0001). Furthermore, patients with bilateral carcinomas demonstrated a significantly higher presence of a tumor capsule (p = 0.012), infiltration of the thyroid capsule (p < 0.0001), and node metastases (p < 0.0001) and a higher incidence of the "tall-cells" variant (p < 0.0001) when compared to the unilateral population.
CONCLUSIONS: Based on these data it is suggested that tumors < or = 1 cm cannot be considered a homogeneous class of DTCs. Nevertheless, in tumors < or = 0.5 cm the absence of a "tall-cells" variant and the absence of infiltration of the thyroid capsule might be useful for avoiding an unnecessary completion thyroidectomy after lobectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17426903     DOI: 10.1007/s00268-006-0795-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

Authors:  R H Cobin; H Gharib; D A Bergman; O H Clark; D S Cooper; G H Daniels; R A Dickey; D S Duick; J R Garber; I D Hay; J S Kukora; H M Lando; A B Schorr; M A Zeiger
Journal:  Endocr Pract       Date:  2001 May-Jun       Impact factor: 3.443

2.  Prognostic implications of the tall cell variant of papillary thyroid carcinoma.

Authors:  T L Johnson; R V Lloyd; N W Thompson; W H Beierwaltes; J C Sisson
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

3.  Fatal carcinoma of the thyroid: histology, metastases, and causes of death.

Authors:  S G Silverberg; R V Hutter; F W Foote
Journal:  Cancer       Date:  1970-04       Impact factor: 6.860

4.  Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients.

Authors:  F Pacini; R Elisei; M Capezzone; P Miccoli; E Molinaro; F Basolo; L Agate; V Bottici; M Raffaelli; A Pinchera
Journal:  Thyroid       Date:  2001-09       Impact factor: 6.568

5.  Importance of tumour size in papillary and follicular thyroid cancer.

Authors:  C Passler; C Scheuba; R Asari; K Kaczirek; K Kaserer; B Niederle
Journal:  Br J Surg       Date:  2005-02       Impact factor: 6.939

6.  Differentiated thyroid carcinoma: the new UICC 6th edition TNM classification system in a retrospective analysis of 169 patients.

Authors:  Natascha Döbert; Christian Menzel; Sabine Oeschger; Frank Grünwald
Journal:  Thyroid       Date:  2004-01       Impact factor: 6.568

7.  Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.

Authors:  K C Loh; F S Greenspan; L Gee; T R Miller; P P Yeo
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

8.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

9.  Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.

Authors:  Ashok R Shaha
Journal:  Laryngoscope       Date:  2004-03       Impact factor: 3.325

10.  Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.

Authors:  Eun Sook Kim; Tae Yong Kim; Jung Min Koh; Young Il Kim; Suck Joon Hong; Won Bae Kim; Young Kee Shong
Journal:  Clin Endocrinol (Oxf)       Date:  2004-07       Impact factor: 3.478

View more
  9 in total

1.  Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.

Authors:  Panchagan Rama Kant Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Prasanta Kumar Pradhan; Sanjay Gambhir; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

2.  Analysis of the clinicopathologic features of papillary thyroid microcarcinoma based on 7-mm tumor size.

Authors:  Kwan Ju Lee; Yun Jung Cho; Say Jun Kim; Sang Chul Lee; Jeong Goo Kim; Chang Joon Ahn; Dong Ho Lee
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

Review 3.  Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.

Authors:  Ning Qu; Ling Zhang; Qing-Hai Ji; Jia-Ying Chen; Yong-Xue Zhu; Yi-Ming Cao; Qiang Shen
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

4.  How many contralateral papillary thyroid carcinomas can be missed?

Authors:  Kwan Ju Lee; Yun Jung Cho; Jeong Goo Kim; Dong Ho Lee
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

5.  Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma.

Authors:  Haitham Alfalah; Isaac Cranshaw; Thomas Jany; Laurent Arnalsteen; Emmanuelle Leteurtre; Catherine Cardot; François Pattou; Bruno Carnaille
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

Review 6.  Minimally invasive video-assisted thyroidectomy for benign thyroid disease: an evidence-based review.

Authors:  Paolo Miccoli; Michele N Minuto; Clara Ugolini; Roberta Pisano; Alessandra Fosso; Piero Berti
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Contralateral papillary thyroid cancer: does size matter?

Authors:  Susan C Pitt; Rebecca S Sippel; Herbert Chen
Journal:  Am J Surg       Date:  2009-03       Impact factor: 2.565

8.  Clinical Analysis of Cervical Lymph Node Metastasis Risk Factors and the Feasibility of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma.

Authors:  Yifan Chen; Shuo Chen; Xiaoying Lin; Xiangqing Huang; Xiaofang Yu; Juying Chen
Journal:  Int J Endocrinol       Date:  2021-01-31       Impact factor: 3.257

9.  [Lymph node dissection in papillary and follicular thyroid cancer].

Authors:  C Vorländer; R H Lienenlüke; R A Wahl
Journal:  Chirurg       Date:  2008-06       Impact factor: 0.920

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.